CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Medpace Holdings, Inc.

MEDP
$17.58BLarge Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for MEDP. That does not mean none is planned.

Get an email about MEDP's next catalysts

Track Medpace Holdings (MEDP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQServices-Commercial Physical & Biological ResearchContract Research OrganizationπŸ‡ΊπŸ‡ΈNorth AmericaCINCINNATI6.0K employees

Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.

Website
Drug Pipeline

Frequently asked questions

What is in Medpace Holdings, Inc.'s drug pipeline?β†’

CatalystAlert tracks 25 drug candidates in Medpace Holdings, Inc.'s (MEDP) pipeline across Phase 3, Phase 2. Its lead program is [18F] Flutemetamol (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Medpace Holdings, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Medpace Holdings, Inc. (MEDP) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track MEDP biotech catalysts?β†’

Add MEDP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Medpace Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply